Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis.

Huang SC, Ng KF, Chen KH, Hsu JT, Liu KH, Yeh TS, Chen TC.

Oncol Rep. 2014 Aug;32(2):530-8. doi: 10.3892/or.2014.3234. Epub 2014 Jun 5.

PMID:
24899228
2.

Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms.

Cheng N, Hui DY, Liu Y, Zhang NN, Jiang Y, Han J, Li HG, Ding YG, Du H, Chen JN, Shao CK.

Gastric Cancer. 2015 Apr;18(2):246-55. doi: 10.1007/s10120-014-0376-9. Epub 2014 Apr 27.

PMID:
24771002
3.

Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.

Min BH, Tae CH, Ahn SM, Kang SY, Woo SY, Kim S, Kim KM.

Gastric Cancer. 2016 Jul;19(3):852-9. doi: 10.1007/s10120-015-0524-x. Epub 2015 Aug 12.

PMID:
26265391
4.

Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.

Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, Cheong JH, Noh SH, Kim H.

Gastric Cancer. 2016 Oct;19(4):1041-51. doi: 10.1007/s10120-015-0565-1. Epub 2015 Nov 16.

PMID:
26573601
5.

Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.

Zhang Y, Chen JN, Dong M, Zhang ZG, Zhang YW, Wu JY, Du H, Li HG, Huang Y, Shao CK.

Hum Pathol. 2017 May;63:128-138. doi: 10.1016/j.humpath.2017.02.016. Epub 2017 Mar 12.

PMID:
28300576
6.

Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis.

Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS.

J Gastroenterol Hepatol. 2009 Mar;24(3):354-65. doi: 10.1111/j.1440-1746.2009.05775.x. Review.

PMID:
19335785
7.

Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.

Dong M, Wang HY, Zhao XX, Chen JN, Zhang YW, Huang Y, Xue L, Li HG, Du H, Wu XY, Shao CK.

Hum Pathol. 2016 Jul;53:25-34. doi: 10.1016/j.humpath.2016.02.007. Epub 2016 Mar 4.

PMID:
26980034
8.

In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis.

Abe H, Morikawa T, Saito R, Yamashita H, Seto Y, Fukayama M.

Virchows Arch. 2016 May;468(5):539-48. doi: 10.1007/s00428-016-1915-z. Epub 2016 Feb 25.

PMID:
26915031
9.

Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.

Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, Chung HY, Yu W, Kang H, Kim JG.

Ann Oncol. 2016 Mar;27(3):494-501. doi: 10.1093/annonc/mdv610. Epub 2015 Dec 16.

PMID:
26673353
10.

Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.

Carrascal E, Koriyama C, Akiba S, Tamayo O, Itoh T, Eizuru Y, Garcia F, Sera M, Carrasquilla G, Piazuelo MB, Florez L, Bravo JC.

Oncol Rep. 2003 Jul-Aug;10(4):1059-62.

PMID:
12792770
11.

Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.

Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsui S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM.

Am J Pathol. 1998 Jan;152(1):191-8.

12.

Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.

Sukawa Y, Yamamoto H, Nosho K, Kunimoto H, Suzuki H, Adachi Y, Nakazawa M, Nobuoka T, Kawayama M, Mikami M, Matsuno T, Hasegawa T, Hirata K, Imai K, Shinomura Y.

World J Gastroenterol. 2012 Dec 7;18(45):6577-86. doi: 10.3748/wjg.v18.i45.6577.

13.

Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.

Chen JN, He D, Tang F, Shao CK.

J Clin Gastroenterol. 2012 Apr;46(4):262-71. doi: 10.1097/MCG.0b013e318249c4b8. Review.

PMID:
22392024
14.

Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.

Koriyama C, Akiba S, Itoh T, Kijima Y, Sueyoshi K, Corvalan A, Herrera-Goepfer R, Eizuru Y.

Int J Mol Med. 2002 Nov;10(5):635-9.

PMID:
12373307
15.
16.

Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma.

Li S, Du H, Wang Z, Zhou L, Zhao X, Zeng Y.

Sci China Life Sci. 2010 Apr;53(4):524-30. doi: 10.1007/s11427-010-0082-8. Epub 2010 May 7.

PMID:
20596921
17.

Epstein-Barr virus-associated gastric carcinoma in Lima, Peru.

Yoshiwara E, Koriyama C, Akiba S, Itoh T, Minakami Y, Chirinos JL, Watanabe J, Takano J, Miyagui J, Hidalgo H, Chacon P, Linares V, Eizuru Y.

J Exp Clin Cancer Res. 2005 Mar;24(1):49-54.

PMID:
15943031
18.

Update on Epstein-Barr virus and gastric cancer (review).

Shinozaki-Ushiku A, Kunita A, Fukayama M.

Int J Oncol. 2015 Apr;46(4):1421-34. doi: 10.3892/ijo.2015.2856. Epub 2015 Jan 28. Review.

PMID:
25633561
19.

Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.

Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K.

Lab Invest. 1994 Jul;71(1):73-81.

PMID:
8041121
20.

Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.

Chen JN, Jiang Y, Li HG, Ding YG, Fan XJ, Xiao L, Han J, Du H, Shao CK.

Virus Res. 2011 Sep;160(1-2):191-9. doi: 10.1016/j.virusres.2011.06.011. Epub 2011 Jun 22.

PMID:
21723347

Supplemental Content

Support Center